ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
ARS Pharmaceuticals | 8-K:重大事件
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
ARS Pharmaceuticals | 10-Q:季度报表
ARS Pharmaceuticals | 8-K:重大事件
ARS Pharmaceuticals | ARS:年度报告
ARS Pharmaceuticals | DEFA14A:其他
ARS Pharmaceuticals | DEF 14A:股东委托书决议
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
ARS Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(11.3%),Peter Kolchinsky(11.3%)等
ARS Pharmaceuticals | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
暂无数据